Teledermatology Implications for Incidental Skin CA Detection

This article originally appeared here.
Share this content:
Teledermatology Implications for Incidental Skin CA Detection
Teledermatology Implications for Incidental Skin CA Detection

TUESDAY, April 14, 2015 (HealthDay News) -- An in-person skin examination is important for detection of incidentally-identified skin malignancies, according to a review published in the April issue of the Journal of the American Academy of Dermatology.

Jaime L. Kingsley-Loso, from the University of Minnesota Medical School in Minneapolis, and colleagues retrospectively reviewed the medical charts of all dermatology consults at the Minneapolis Department of Veterans Affairs Medical Center over 8.25 years.

Of the 17,174 included consults; the researchers found that 2,257 patients (13.1 percent) had one or more biopsied incidental lesions. Of the 3,328 biopsied incidental lesions, half were malignant (this included 1,187 patients). For an incidental malignant lesion, the per-person detection rate was 6.9 percent. In 84 patients there were 87 incidental melanomas identified (a per-person detection rate of 0.5 percent). For biopsied incidental malignancies, the most frequent anatomical location was the head and neck (53.9 percent), with incidental melanomas most frequently located on the back (33.3 percent).

"An in-person skin examination by a trained dermatologist is important for detection of skin malignancies," the authors write. "This may have implications for teledermatology."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »